Five-Year Optical Coherence Tomography Follow-Up of an Everolimus-Eluting Bioresorbable Vascular Scaffold: Changing the Paradigm of Coronary Stenting?

A. Karanasos, C. Simsek, P. Serruys, J. Ligthart, K. Witberg, R.-J. van Geuns, G. Sianos, F. Zijlstra, E. Regar
  • Circulation, August 2012, Wolters Kluwer Health
  • DOI: 10.1161/circulationaha.112.110122

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

The following have contributed to this page: Dr E Regar